31 – 40 of 100
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Inflammation without neuronal death triggers striatal neurogenesis comparable to stroke.
(
- Contribution to journal › Article
-
Mark
Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
(
- Contribution to journal › Article
-
Mark
A cell culture model for monitoring α-synuclein cell-to-cell transfer.
(
- Contribution to journal › Article
-
Mark
Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models.
(
- Contribution to journal › Article
-
Mark
Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function.
(
- Contribution to journal › Article
-
Mark
Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis.
(
- Contribution to journal › Scientific review
-
Mark
Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Reconstruction of brain circuitry by neural transplants generated from pluripotent stem cells.
(
- Contribution to journal › Scientific review
-
Mark
Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?
(
- Contribution to journal › Scientific review